1,729 results on '"Hofmann, Wolf-Karsten"'
Search Results
2. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms
3. A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis
4. Prospective analysis of the attendance behaviour of the participants of a facilitated support group for patients after allogeneic hematopoietic cell transplantation
5. Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level
6. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort
7. Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
8. Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies
9. Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
10. Understanding iron homeostasis in MDS: the role of erythroferrone
11. Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at single cell level
12. Differential effects of sound interventions tuned to 432 Hz or 443 Hz on cardiovascular parameters in cancer patients: A randomized cross-over trial
13. Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany
14. Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
15. Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
16. Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis
17. Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosis
18. Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes
19. Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states
20. Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis
21. Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group
22. Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)
23. Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis
24. Hemodynamic and Stress Response After Sound Intervention with Different Headphone Systems: A Double-Blind Randomized Study in Healthy Volunteers Working in the Health Care Sector.
25. Influence of the Insertion Site on Central Venous Catheter-Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
26. Treatment-free remission in FIP1L1-PDGFRA–positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation
27. Prospective analysis of the attendance behaviour of the participants of a facilitated support group for patients after allogeneic hematopoietic cell transplantation
28. Hemodynamic and Stress Response After Sound Intervention with Different Headphone Systems: A Double-Blind Randomized Study in Healthy Volunteers Working in the Health Care Sector
29. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
30. Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo
31. Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
32. Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients
33. An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis
34. Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
35. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance
36. Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis
37. Diagnostik und Management des myelodysplastischen Syndroms
38. Myelodysplastische Syndrome
39. Incidence of Cyp51 A key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995-2013.
40. S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL
41. S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME HARBORING DEL(5Q). A HARMONY ALLIANCE STUDY
42. P1036: REAL-WORLD EFFICACY AND SAFETY OF MIDOSTAURIN-TREATMENT IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
43. Reverse Transcription Can Critically Impact the Diagnostic Outcome of BCR::ABL1 Quantitative Real-Time RT-PCR
44. 4. Zukünftige Aspekte der Diagnostik und Therapie myeloischer Neoplasien
45. Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial
46. Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS
47. Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial
48. Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation
49. Cancer patients and music: (prospective) results from a survey to evaluate potential complementary treatment approaches
50. Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.